NASDAQ : JAGX
Jaguar Health, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.62 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 842.63K
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Jaguar Health, Inc. (JAGX) reported revenue of 27.82M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 27.82M | 11.51M | 11.69M | 9.76M | 11.96M | 4.33M |
| Cost of Revenue | 4.92M | 3.77M | 1.96M | 2.04M | 2.02M | 2.33M |
| Gross Profit | 22.89M | 7.74M | 9.73M | 7.72M | 9.94M | 2.00M |
| Selling, General & Admin | 22.75M | 27.88M | 24.02M | 23.05M | 26.70M | 26.00M |
| Research & Development | 25.23M | 24.97M | 16.54M | 18.60M | 17.65M | 15.08M |
| Operating Expenses | 47.99M | 52.84M | 40.56M | 41.64M | 44.35M | 41.08M |
| Operating Income | -25.09M | -45.11M | -30.83M | -33.92M | -34.41M | -39.07M |
| Interest Expense | -998.00K | -67.00K | -231.00K | -6.38M | -12.72M | -8.42M |
| Other Non Operating Income (Expenses) | -5.92M | -6.22M | -9.43M | -4.92M | 930.00K | -2.72M |
| EBT Excluding Unusual Items | -32.01M | -51.40M | -40.50M | -45.23M | -46.21M | -50.21M |
| Asset Writedown | -371.00K | |||||
| Other Unusual Items | -4.11M | -1.80M | 1.25M | 3.70M | -2.19M | -2.39M |
| Pretax Income | -36.92M | -54.00M | -39.25M | -41.90M | -48.40M | -52.60M |
| Earnings From Continuing Operations | -36.92M | -54.00M | -39.25M | -41.90M | -48.40M | -52.60M |
| Minority Interest in Earnings | 524.00K | 563.00K | 759.00K | 601.00K | 941.00K | 5.00K |
| Net Income | -36.40M | -53.43M | -38.49M | -41.30M | -47.45M | -52.59M |
| Preferred Dividends & Other Adjustments | 16.02M | 141.00K | ||||
| Net Income to Common | -52.42M | -53.58M | -38.49M | -41.30M | -47.45M | -52.59M |
| Shares Outstanding (Basic) | 22.42K | |||||
| Shares Outstanding (Diluted) | 22.42K | |||||
| EPS (Basic) | -2,338.09 | |||||
| EPS (Diluted) | -2,338.09 | |||||
| Free Cash Flow | -6.73M | -23.73M | -29.40M | -33.24M | -33.18M | -34.98M |
| Free Cash Flow Per Share | -300.00 | |||||
| Gross Margin | 82.31% | 67.21% | 83.28% | 79.13% | 83.11% | 46.18% |
| Operating Margin | -90.22% | -391.87% | -263.76% | -347.50% | -287.85% | -901.36% |
| Profit Margin | -188.46% | -465.42% | -329.30% | -423.11% | -396.91% | -1,213.26% |
| Free Cash Flow Margin | -24.18% | -206.12% | -251.52% | -340.56% | -277.53% | -806.83% |
| EBITDA | -23.19M | -43.20M | -28.93M | -31.91M | -32.43M | -37.35M |
| EBITDA Margin | -83.38% | -247.51% | -271.28% | |||
| D&A For EBITDA | 1.90M | 1.91M | 1.90M | 2.01M | 1.98M | 1.72M |
| EBIT | -25.09M | -45.11M | -30.83M | -33.92M | -34.41M | -39.07M |
| EBIT Margin | -90.22% | -263.76% | -287.85% | |||
| Revenue as Reported | 27.82M | 11.51M | 11.69M | 9.76M | 4.33M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 3.79M | 968.00K | 8.00M | 6.47M | 5.47M | 17.05M |
| Cash & Short-Term Investments | 3.79M | 968.00K | 8.00M | 6.47M | 5.47M | 17.05M |
| Accounts Receivable | 8.00K | 1.52M | 1.53M | 1.97M | 1.88M | 1.71M |
| Other Receivables | 190.00K | 177.00K | 120.00K | 217.00K | 588.00K | 435.00K |
| Receivables | 198.00K | 1.70M | 1.65M | 2.18M | 2.47M | 2.14M |
| Inventory | 7.32M | 8.60M | 10.35M | 9.19M | 7.02M | 4.90M |
| Prepaid Expenses | 3.43M | 2.22M | 12.20M | 10.12M | 7.36M | 4.34M |
| Restricted Cash | 2.80M | 6.86M | ||||
| Total Current Assets | 17.53M | 20.34M | 32.20M | 27.96M | 22.32M | 28.43M |
| Property, Plant & Equipment | 1.43M | 1.46M | 1.40M | 1.67M | 1.70M | 1.73M |
| Other Intangible Assets | 15.09M | 16.02M | 18.48M | 20.12M | 22.44M | 22.65M |
| Other Long-Term Assets | 147.00K | 494.00K | 1.35M | 1.01M | 995.00K | 446.00K |
| Total Assets | 34.19M | 38.32M | 53.42M | 50.76M | 47.45M | 53.27M |
| Accounts Payable | 4.79M | 8.69M | 5.29M | 4.97M | 5.81M | 4.93M |
| Accrued Expenses | 3.12M | 2.43M | 1.38M | 3.80M | 8.16M | 7.12M |
| Short-Term Debt | 371.00K | 164.00K | 135.00K | 172.00K | ||
| Current Portion of Long-Term Debt | 13.46M | 27.28M | 11.90M | 4.70M | 15.88M | 3.18M |
| Current Portion of Leases | 219.00K | 192.00K | 299.00K | 348.00K | 483.00K | 240.00K |
| Current Unearned Revenue | 170.00K | 170.00K | 170.00K | |||
| Other Current Liabilities | 1.59M | 1.73M | 533.00K | 1.00K | ||
| Total Current Liabilities | 23.73M | 40.65M | 19.70M | 13.99M | 30.34M | 15.47M |
| Long-Term Debt | 1.73M | 15.08M | 23.50M | 30.99M | 17.74M | 25.02M |
| Long-Term Leases | 873.00K | 892.00K | 686.00K | 886.00K | 725.00K | 919.00K |
| Long-Term Unearned Revenue | 298.00K | 382.00K | 553.00K | |||
| Other Long-Term Liabilities | 996.00K | |||||
| Total Liabilities | 27.62M | 57.01M | 44.45M | 45.87M | 48.81M | 41.41M |
| Common Stock | 1.00K | |||||
| Additional Paid-In Capital | 411.61M | 380.97M | 354.23M | 313.86M | 266.97M | 231.10M |
| Retained Earnings | -403.75M | -399.92M | -346.48M | -308.25M | -266.95M | -219.49M |
| Comprehensive Income & Other | -1.24M | -833.00K | -467.00K | -652.00K | -680.00K | |
| Total Common Equity | 6.62M | -19.77M | 7.29M | 4.96M | -657.00K | 11.61M |
| Minority Interest | -1.69M | -1.40M | -791.00K | -64.00K | -699.00K | 242.00K |
| Shareholders' Equity | 6.57M | -18.69M | 8.98M | 4.90M | -1.36M | 11.85M |
| Total Liabilities & Equity | 34.19M | 38.32M | 53.42M | 50.76M | 47.45M | 53.27M |
| Total Debt | 16.65M | 43.61M | 36.53M | 37.09M | 34.84M | 29.36M |
| Net Cash (Debt) | -12.86M | -42.64M | -28.52M | -30.62M | -29.37M | -12.31M |
| Net Cash Per Share | -573.73 | |||||
| Filing Date Shares Outstanding | 344.55K | 24.80K | ||||
| Total Common Shares Outstanding | 323.81K | 13.29K | ||||
| Working Capital | -6.19M | -20.31M | 12.49M | 13.98M | -8.02M | 12.96M |
| Book Value Per Share | 20.43 | -1,488.00 | ||||
| Tangible Book Value | -8.47M | -35.80M | -11.19M | -15.15M | -23.10M | -11.04M |
| Tangible Book Value Per Share | -26.16 | -2,693.58 | ||||
| Land | 396.00K | 396.00K | 396.00K | 396.00K | 396.00K | 396.00K |
| Machinery | 528.00K | 562.00K | 518.00K | 502.00K | 502.00K | 489.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -36.40M | -53.43M | -38.49M | -41.30M | -47.45M | -52.59M |
| Depreciation & Amortization | 2.16M | 2.20M | 2.36M | 2.39M | 2.29M | 1.81M |
| Other Amortization | 585.00K | 153.00K | 274.00K | 13.21M | 11.76M | 5.17M |
| Asset Writedown & Restructuring Costs | 800.00K | 800.00K | 371.00K | |||
| Loss (Gain) on Equity Investments | 123.00K | 162.00K | 138.00K | 51.00K | ||
| Stock-Based Compensation | 577.00K | 831.00K | 1.65M | 2.28M | 4.14M | 3.99M |
| Other Operating Activities | 11.11M | 9.09M | 7.70M | 858.00K | 587.00K | 4.38M |
| Change in Accounts Receivable | 1.17M | 6.00K | 440.00K | -88.00K | -170.00K | 2.82M |
| Change in Inventory | 1.40M | -254.00K | -1.16M | -2.17M | -2.12M | -2.12M |
| Change in Accounts Payable | -1.83M | 3.35M | 328.00K | -855.00K | 902.00K | 158.00K |
| Change in Unearned Revenue | -170.00K | -171.00K | 723.00K | |||
| Change in Other Net Operating Assets | 13.79M | 13.58M | -3.35M | -7.99M | -3.04M | 1.40M |
| Operating Cash Flow | -6.68M | -23.69M | -29.38M | -33.24M | -33.10M | -34.97M |
| Capital Expenditures | -41.00K | -41.00K | -16.00K | -77.00K | -6.00K | |
| Sale (Purchase) of Intangibles | -215.00K | -1.60M | ||||
| Investing Cash Flow | -41.00K | -41.00K | -231.00K | -1.68M | -6.00K | |
| Short-Term Debt Issued | 10.00M | 3.98M | ||||
| Long-Term Debt Issued | 3.44M | 11.03M | ||||
| Total Debt Issued | 10.00M | 13.45M | 3.98M | 11.03M | ||
| Short-Term Debt Repaid | -652.00K | -608.00K | -853.00K | -1.16M | -943.00K | |
| Long-Term Debt Repaid | -100.00K | -100.00K | -100.00K | -100.00K | -1.92M | |
| Total Debt Repaid | -7.10M | -752.00K | -708.00K | -953.00K | -1.26M | -2.87M |
| Net Debt Issued (Repaid) | 2.90M | 12.69M | -708.00K | -953.00K | 2.72M | 8.16M |
| Issuance of Common Stock | 4.14M | 8.74M | 32.07M | 32.34M | 20.57M | 38.63M |
| Other Financing Activities | 56.00K | -145.00K | -157.00K | 2.21M | -103.00K | -2.85M |
| Financing Cash Flow | 11.30M | 23.67M | 31.20M | 34.23M | 23.18M | 43.94M |
| Foreign Exchange Rate Adjustments | -187.00K | -113.00K | -54.00K | 15.00K | 16.00K | |
| Net Cash Flow | 4.38M | -170.00K | 1.53M | 1.00M | -11.58M | 8.96M |
| Free Cash Flow | -6.73M | -23.73M | -29.40M | -33.24M | -33.18M | -34.98M |
| Free Cash Flow Margin | -24.18% | -206.12% | -251.52% | -340.56% | -277.53% | -806.83% |
| Free Cash Flow Per Share | -300.00 | |||||
| Levered Free Cash Flow | -1.78M | -14.62M | -19.47M | -17.15M | -16.49M | -17.78M |
| Unlevered Free Cash Flow | -1.74M | -14.73M | -19.60M | -26.37M | -20.29M | -17.69M |
| Cash Interest Paid | 19.00K | 22.00K | 14.00K | 35.00K | 23.00K | 28.00K |
| Change in Working Capital | 14.35M | 16.51M | -3.01M | -11.10M | -4.43M | 2.27M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 842.63K | 4.22M | 11.90M | 7.63M | 10.28M | |
| Enterprise Value | 13.71M | 33.81M | 34.88M | 40.00M | 32.57M | 15.46M |
| Last Close Price | 1.62 | 488.88 | 13,256.26 | 119,231.38 | 5,142,012.00 | 61,538,462.00 |
| PS Ratio | 0.03 | 0.37 | 1.02 | 0.78 | 0.86 | |
| PB Ratio | 0.08 | -0.23 | 1.33 | 1.56 | -7.58 | |
| EV/Sales Ratio | 0.49 | 2.94 | 2.98 | 4.10 | 2.72 | 3.56 |
| Debt / Equity Ratio | 2.53 | -2.33 | 4.07 | 7.58 | -25.69 | 2.48 |
| Net Debt / Equity Ratio | 1.96 | -2.28 | 3.18 | 6.25 | -21.66 | 1.04 |
| Net Debt / EBITDA Ratio | -0.56 | -0.99 | -0.99 | -0.96 | -0.91 | -0.33 |
| Net Debt / FCF Ratio | -1.91 | -1.80 | -0.97 | -0.92 | -0.89 | -0.35 |
| Asset Turnover | 0.68 | 0.25 | 0.22 | 0.20 | 0.24 | 0.09 |
| Inventory Turnover | 0.55 | 0.40 | 0.20 | 0.25 | 0.34 | 0.61 |
| Quick Ratio | 0.17 | 0.07 | 0.49 | 0.62 | 0.26 | 1.24 |
| Current Ratio | 0.74 | 0.50 | 1.63 | 2.00 | 0.74 | 1.84 |
| Return on Equity (ROE) | -548.83% | -565.74% | -2,366.62% | -922.07% | -362.07% | |
| Return on Assets (ROA) | -38.04% | -61.46% | -36.99% | -43.17% | -42.71% | -50.82% |
| Return on Capital Employed (ROCE) | -239.80% | 1,935.10% | -91.40% | -92.20% | -201.10% | -103.40% |
| Earnings Yield | -144,326.60% | -1,265.03% | -323.35% | -541.23% | -461.43% | |
| FCF Yield | -798.22% | -561.73% | -246.97% | -435.63% | -322.65% |